У нас вы можете посмотреть бесплатно Hitachi Aloka Medical Improves Real-Time Intraoperative Visualization with New Ultrasound Probe или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Surgical ultrasound leader Hitachi Aloka Medical America, Inc. has created a new ultrasound probe specifically for subcortical brain surgery to provide neurosurgeons with real-time, intraoperative imaging feedback. The probe is FDA cleared and was specifically designed for use with the NICO BrainPath® as a means to assist with sulcal identification through the dura, greater extent of resection during the tumor removal procedure, and locating a tumor that has rolled during resection. Dr. Juan Alzate, neurosurgeon with The American Center for Spine and Neurosurgery and Cancer Treatment Centers of America in Chicago, says the combination of the technologies are useful to assist surgeons in precisely and efficiently locating tumors beyond their direct vision in the surgical field. You can watch a video of the technologies working together HERE. “With the immediate feedback it provides surgeons within a minimally invasive corridor, they can confirm location of the brain tumor, proximity of nearby vessels that may be encountered beyond the direct field of view and confirms the extent of the resection,” Alzate said. “It also allows for the efficiency of an ultrasound with the economic value.” David Famiglietti, president and GM of Hitachi Aloka Medical America, said Hitachi Aloka Medical's ultrasound imaging is being used by surgeons in various disciplines to improve accuracy and precision during the resection of tumors. “For a field as complex as neurosurgery, we are excited to bring this innovative new solution for minimally invasive, yet highly effective surgical site visualization and access,” Famiglietti said. “Ultimately, our goal is to provide patients with brain abnormalities both better and safer options for treatment.”